Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) Files An 8-K Other Events

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) Files An 8-K Other Events
Item 8.01.

Story continues below

Other Events.

On February 21, 2019, Ohr Pharmaceutical, Inc. (the Company) issued a press release announcing that it received notice from The Nasdaq Stock Market LLC indicating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

(d)

Exhibits:

99.1 Press release, dated February 21, 2019

Ohr Pharmaceutical Inc Exhibit
EX-99.1 2 ex99-1.htm PRESS RELEASE   Ohr Pharmaceutical,…
To view the full exhibit click here

An ad to help with our costs